ACT Genomics launched a brand-new ACTOnco?+


The brand-new ACTOnco®+ features a comprehensive testing of 440 cancer-related genes and now provides therapeutic implications for targeted therapy, chemotherapy, hormone therapy and PARP1 inhibitors. ACTOnco®+ covers most of the key signaling pathways related to cancer, identifying more drug options for patients. In addition, ACTOnco®+ uses mutation burden, immune-related gene information and MSI status to provide a more accurate prediction of immunotherapy response.

More details on ACTOnco®+:

青娱极品盛宴国产分类-亚洲 欧美 日韩 国产 制服-国产爆乳合集在线视频,五月色婷婷,久久热在线视频,免费网站看v片在线薰衣草